Vaxart and Westwood & Wilshire Collaborate to Appoint Vice President of IT
April 25, 2022, South San Francisco, CA— Vaxart, a clinical-stage biotechnology company, has brought on James Lay as Vice President of Information Technology. The company is developing a range of oral vaccines which could dramatically improve patient acceptance, reduce supply chain costs, and increase vaccination rates globally.
Currently in Phase II trials, Vaxart’s S-Only COVID-19 vaccine candidate has successfully generated antibodies to the original COVID-19 virus strain and to the beta, delta, alpha and gamma variants in the serum and nasal mucosa of non-human primates. Vaxart plans to build upon their strong momentum by launching additional studies in 2022.
James joins after serving as Senior Director of Information Technology at Notable, a mission-driven company transforming the way cancer is treated. James has previously held IT leadership roles at several companies focused on medical device manufacturing and biotech research, including Thoratec (acquired by Abbott Labs), Solta Medical (acquired by Bausch Health), and Labcyte (acquired by Beckman-Coulter LS).
The search was led successfully by Andrea Tegstam for Westwood & Wilshire’s Technology practice.
About Westwood & Wilshire
Westwood & Wilshire is a retained executive search firm that recognizes people as any organization’s top asset. The firm has delivered premier talent to many of the world’s most innovative companies in life sciences, healthcare, and advanced technology. Westwood & Wilshire specializes in bringing top-tier candidates at the mid-management to C-Suite level to clients ranging from VC backed start-ups to mid-sized commercial entities. The firm has offices in Los Angeles, Silicon Valley, Scottsdale, and Connecticut serving clients worldwide.
